ONCTUS68236P1075

Oncternal Therapeutics Reports Granting of an Inducement Award Under Nasdaq Listing Rule 5635(4)

13 days ago   |   San Diego Biotechnology   |   2 articles

SAN DIEGO, Feb. 22, 2021 - Oncternal Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced...
Read more ...

Oncternal Therapeutics Announces the Appointment of Dr. Rosemary Mazanet to the Board of Directors

1 month ago   |   San Diego Biotechnology   |   3 articles

SAN DIEGO, Jan. 28, 2021 - Oncternal Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the...
Read more ...

Oncternal Therapeutics to Participate in Fireside Chat at H.C. Wainwright BioConnect 2021 Conference

2 monthes ago   |   San Diego Biotechnology   |   3 articles

SAN DIEGO, Jan. 05, 2021 - Oncternal Therapeutics , today announced that James Breitmeyer, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside...
Read more ...

Oncternal Therapeutics Announces Presentation of Interim Phase 1/2 Data Update for Cirmtuzumab in Combination with Ibrutinib at ASH 2020 Virtual Annual Meeting

3 monthes ago   |   San Diego Biotechnology   |   2 articles

SAN DIEGO, Dec. 07, 2020 - Oncternal Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced...
Read more ...

Oncternal Therapeutics Announces $20.0 Million Bought Deal Offering

3 monthes ago   |   San Diego Biotechnology   |   5 articles

SAN DIEGO, Nov. 17, 2020 - Oncternal Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced...
Read more ...

Oncternal Therapeutics Increases Previously Announced Bought Deal to $22.5 Million

3 monthes ago   |   San Diego Biotechnology   |   5 articles

SAN DIEGO, Nov. 17, 2020 - Oncternal Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced...
Read more ...

Oncternal Announces Third Quarter 2020 Financial Results and Provides Business Update

4 monthes ago   |   San Diego Biotechnology

SAN DIEGO, Nov. 04, 2020 - Oncternal Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today provided a...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Berkeley Lab Innovation Supports Thousands of Jobs Across the Bay Area and...

Berkeley Lab Innovation Supports Thousands of Jobs Across the Bay Area and Nation

Berkeley Lab's Advanced Light Source at sunset. The U.S. Department of Energy's Lawrence Berkeley National Laboratory supports more than 10,000 jobs in the Bay Area and nearly... Read more ...

Enhanced Vitamin E content in an Indica rice cultivar harbouring two...

Abstract Micronutrient deficiency results in malnutrition, which is prevalent all over the world and may lead to premature death in women and children. Strategies formulated... Read more ...

BED domain‐containing NLR from wild barley confers resistance to leaf rust

Summary Leaf rust, caused by Puccinia hordei, is a devastating fungal disease affecting barley production globally. Despite the effectiveness of genetic resistance, the... Read more ...

The OsmiRNA166b‐OsHox32 pair regulates mechanical strength of rice plants by...

Summary The plant cell wall provides mechanical strength to support plant growth and development and to determine plant architecture. Cellulose and mixed‐linkage glucan present... Read more ...

Seeing is believing: a visualization toolbox to enhance selection efficiency...

Abstract The emerging and promising biotechnology methodology of CRISPR/Cas9 gene‐editing is revolutionizing crop improvement. However, the low‐efficiency, time‐consuming, and... Read more ...

Developing a Nicotiana benthamiana transgenic platform for high‐value...

Summary To engineer Nicotiana benthamiana to produce novel diterpenoids, we first aimed to increase production of the diterpenoid precursor geranylgeranyl pyrophosphate by... Read more ...

Generation of novel self‐incompatible Brassica napus by CRISPR/Cas9

Abstract Self‐incompatibility is a genetic mechanism that prevents inbreeding in hermaphrodite angiosperms via the rejection of self‐pollen. SI lines facilitate the utilization... Read more ...

Advanced domestication: harnessing the precision of gene editing in crop...

Summary Human population growth has increased the demand for food crops, animal feed, biofuel and biomaterials, all the while climate change is impacting environmental growth... Read more ...

Long‐range assembly of sequences helps to unravel the genome structure and...

Summary Genomics studies in wild species of wheat have been limited due to the lack of references; however, new technologies and bioinformatics tools have much potential to... Read more ...

The role of VvMYBA2r and VvMYBA2w alleles of the MYBA2 locus in the...

Summary In grape, MYBA1 and MYBA2 at the colour locus are the major genetic determinants of grape skin colour, and the mutation of two functional genes from these loci leads to... Read more ...